A pair of Republican congressmen is demanding answers from the Food and Drug Administration (FDA) over the continued lack of regulations for CBD as food items and dietary supplements.
Reps. Morgan Griffith (R-VA) and Brett Guthrie (R-KY) sent a letter to FDA Commissioner Robert Califf on Monday, expressing concerns about the protracted timeline for CBD rulemaking since the hemp-derived cannabinoid was federally legalized under the 2018 Farm Bill and the resulting “significant marketplace disruptions and regulatory uncertainly.”
The lawmakers said that they understand FDA is continuing to collect scientific data on the safety of CBD in the food supply—and that it intends to work with the agency’s independent non-profit Reagan-Udall Foundation to evaluate regulatory processes overall—but they want FDA to answer to Congress in the interim.
“The United States currently has a robust but largely unregulated CBD market, which leads to an unsafe marketplace for consumers,” they wrote. “Consumer products that contain CBD—such as dietary supplements, food, and beverages—are currently sold across the country under a patchwork of state laws and regulations that have been developed and promulgated in light of FDA’s inaction.”
“This has even led to multiple cases of children purchasing over-the-counter CBD gummies with unsafe levels of
Read full article on Marijuana Moment
